Provided by Tiger Fintech (Singapore) Pte. Ltd.

Progenics Pharmaceuticals

4.10
+0.0000
Volume:- -
Turnover:- -
Market Cap:355.05M
PE:-5.30
High:4.10
Open:4.10
Low:4.10
Close:4.10
Loading ...
Feb 20, 2020

Business Combinations

Prospectuses and communications, business combinations
Feb 20, 2020

Business Combinations

Prospectuses and communications, business combinations
Feb 20, 2020

Major Issues Report

Current report, items 8.01 and 9.01
Feb 20, 2020

Business Combinations

Prospectuses and communications, business combinations
Feb 20, 2020

Business Combinations

Prospectuses and communications, business combinations
Feb 14, 2020

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals
Feb 14, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 14, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 13, 2020

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals
Feb 11, 2020

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals
Feb 04, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Jan 21, 2020

Major Issues Report

Current report, items 7.01 and 9.01
Jan 10, 2020

Business Combinations

Prospectuses and communications, business combinations
Jan 08, 2020

Business Combinations

Prospectuses and communications, business combinations
Jan 06, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Dec 23, 2019

Major Issues Report

Current report, items 7.01 and 9.01
Dec 19, 2019

Major Issues Report

Current report, item 5.02
Nov 21, 2019

Major Issues Report

Current report, items 5.02, 7.01, and 9.01
Nov 15, 2019

Major Issues Report

Current report, items 5.02, 5.03, 5.07, and 9.01
Nov 12, 2019

Beneficial Ownership Change

[Amend] General statement of acquisition of beneficial ownership